Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Steven Simonson Insider Profile
4 Followers
Steven Simonson, SVP, Chief Medical Officer at Windtree Therapeutics, holds 11.09K shares in Windtree Therapeutics (Ticker: WINT). Most recently, Steven Simonson Bought $517 shares of Windtree Therapeutics on May 27, 2020 for an estimated value of 3.75K.
Steven Simonson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Steven Simonson's holdings
Insider Roles
SVP, Chief Medical Officer
Roles that Steven Simonson holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 27, 2020 - May 27, 2021
Return:-4.40%
The most profitable trade made by Steven Simonson
Steven Simonson's Trading History
List of latest transactions for each holding click on a transaction to see Steven Simonson's performance on stock
You May Also Like
Steven Simonson insider profile FAQ
What is the percentage of profitable transactions made by Steven Simonson?
The percentage of profitable transactions made by Steven Simonson is ―.
What is the average return per transaction made by Steven Simonson?
The average return per transaction made by Steven Simonson is ―.
What stocks does Steven Simonson hold?
Steven Simonson holds: WINT stocks.
What was Steven Simonson’s latest transaction?
Steven Simonson latest transaction was an Informative Buy of $3.75K.
What was Steven Simonson's most profitable transaction?
Steven Simonson’s most profitable transaction was an Informative Buy of WINT stock on May 27, 2020. The return on the trade was -4.40%.
What is Steven Simonson's role in Windtree Therapeutics?
Steven Simonson's role in Windtree Therapeutics is SVP, Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.